Announcements Trials
Browse Landscape

Phase

Phase NA 9Phase 2 2Phase 1 1

Status

Recruiting 2Completed 2Unknown 1Terminated 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 2

Conditions

Vulvar Neoplasms 1Postoperative Complications 1Neoplasms 1Lymphedema 1Endometrial Neoplasms 1

Interventions

Cyclophosphamide 739Cisplatin 687Gemcitabine 641Bevacizumab 615Carboplatin 604Paclitaxel 600Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 360Capecitabine 342Filgrastim 333Etoposide 328Dexamethasone 312Irinotecan 309pembrolizumab 279Leucovorin 274Cetuximab 267Cytarabine 242Erlotinib Hydrochloride 231Prednisone 227Nivolumab 227Trastuzumab 225Bortezomib 221Vincristine 220Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Completed × Lymph Node Excision × Clear all
NCT01512810 2021-11-24

Intraoperative Pathological Evaluation for Surgical Treatment & Staging for Endometrial Cancer

University of Kentucky

Phase 2 Completed
200 enrolled
Gynecologic

Neoplasms, Endometrial Neoplasms

NCT01406769 2021-05-07

Bioimpedance Spectroscopy in Detecting Lower-Extremity Lymphedema in Patients With Stage I, Stage II, Stage III, or Stage IV Vulvar Cancer Undergoing Surgery and Lymphadenectomy

GOG Foundation

Phase 2 Completed
120 enrolled
Gynecologic

Lymphedema, Postoperative Complications, Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡